カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

ポリオワクチンの世界市場2022：不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV）

■ 英語タイトル：Global Poliovirus Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22DC3896）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22DC3896
■ 発行日：2023年1月
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：93
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥522,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥783,000見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,044,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ポリオワクチンの世界市場2022：不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

世界のポリオワクチン市場レポートは、グローバル市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
Global Info Research社の最新のリサーチによると、世界のポリオワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

ポリオワクチン市場はタイプとアプリケーションによって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメントは次をカバーします。
・不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV）

アプリケーション別セグメントは次のように区分されます。
・公用、民間用

世界のポリオワクチン市場の主要な市場プレーヤーは以下のとおりです。
・Sanofi、GSK、Bibcol、Serum Institute、Tiantan Biological、IMBCA、Panacea Biotec Ltd、Bio-Med、Halfkin Bio-Pharmaceuticals

地域別セグメントは次の地域・国をカバーします。
・北米（アメリカ、カナダ、メキシコ）
・欧州（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南米（ブラジル、アルゼンチン、コロンビア）
・中東/アフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査資料の内容は計15章あります。
・第1章では、ポリオワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なポリオワクチンメーカーの企業概要、2019年～2022年までのポリオワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なポリオワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別ポリオワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までのポリオワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域でのポリオワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、およびポリオワクチンの産業チェーンを掲載しています。
・第13、14、15章では、ポリオワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
– ポリオワクチンの概要
– 種類別分析（2017年vs2021年vs2028年）：不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV）
– 用途別分析（2017年vs2021年vs2028年）：公用、民間用
– 世界のポリオワクチン市場規模・予測
– 世界のポリオワクチン生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Sanofi、GSK、Bibcol、Serum Institute、Tiantan Biological、IMBCA、Panacea Biotec Ltd、Bio-Med、Halfkin Bio-Pharmaceuticals
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV）
・用途別分析2017年-2028年：公用、民間用
・ポリオワクチンの北米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ポリオワクチンのヨーロッパ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ポリオワクチンのアジア市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ポリオワクチンの南米市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ポリオワクチンの中東・アフリカ市場
– 種類別市場規模2017年-2028年
– 用途別市場規模2017年-2028年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Poliovirus Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Poliovirus Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Inactivated Polio Vaccine (IPV)
1.2.3 Oral Polio Vaccine (OPV)
1.3 Market Analysis by Application
1.3.1 Overview: Global Poliovirus Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Public
1.3.3 Private
1.4 Global Poliovirus Vaccine Market Size & Forecast
1.4.1 Global Poliovirus Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Poliovirus Vaccine Sales in Volume (2017-2028)
1.4.3 Global Poliovirus Vaccine Price (2017-2028)
1.5 Global Poliovirus Vaccine Production Capacity Analysis
1.5.1 Global Poliovirus Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Poliovirus Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Poliovirus Vaccine Market Drivers
1.6.2 Poliovirus Vaccine Market Restraints
1.6.3 Poliovirus Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business
2.1.3 Sanofi Poliovirus Vaccine Product and Services
2.1.4 Sanofi Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 GSK
2.2.1 GSK Details
2.2.2 GSK Major Business
2.2.3 GSK Poliovirus Vaccine Product and Services
2.2.4 GSK Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Bibcol
2.3.1 Bibcol Details
2.3.2 Bibcol Major Business
2.3.3 Bibcol Poliovirus Vaccine Product and Services
2.3.4 Bibcol Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Serum Institute
2.4.1 Serum Institute Details
2.4.2 Serum Institute Major Business
2.4.3 Serum Institute Poliovirus Vaccine Product and Services
2.4.4 Serum Institute Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Tiantan Biological
2.5.1 Tiantan Biological Details
2.5.2 Tiantan Biological Major Business
2.5.3 Tiantan Biological Poliovirus Vaccine Product and Services
2.5.4 Tiantan Biological Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 IMBCA
2.6.1 IMBCA Details
2.6.2 IMBCA Major Business
2.6.3 IMBCA Poliovirus Vaccine Product and Services
2.6.4 IMBCA Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Panacea Biotec Ltd
2.7.1 Panacea Biotec Ltd Details
2.7.2 Panacea Biotec Ltd Major Business
2.7.3 Panacea Biotec Ltd Poliovirus Vaccine Product and Services
2.7.4 Panacea Biotec Ltd Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Bio-Med
2.8.1 Bio-Med Details
2.8.2 Bio-Med Major Business
2.8.3 Bio-Med Poliovirus Vaccine Product and Services
2.8.4 Bio-Med Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Halfkin Bio-Pharmaceuticals
2.9.1 Halfkin Bio-Pharmaceuticals Details
2.9.2 Halfkin Bio-Pharmaceuticals Major Business
2.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product and Services
2.9.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Poliovirus Vaccine Breakdown Data by Manufacturer
3.1 Global Poliovirus Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Poliovirus Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Poliovirus Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Poliovirus Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Poliovirus Vaccine Manufacturer Market Share in 2021
3.5 Global Poliovirus Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Poliovirus Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Poliovirus Vaccine Market Size by Region
4.1.1 Global Poliovirus Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Poliovirus Vaccine Revenue by Region (2017-2028)
4.2 North America Poliovirus Vaccine Revenue (2017-2028)
4.3 Europe Poliovirus Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Poliovirus Vaccine Revenue (2017-2028)
4.5 South America Poliovirus Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Poliovirus Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Poliovirus Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Poliovirus Vaccine Revenue by Type (2017-2028)
5.3 Global Poliovirus Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Poliovirus Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Poliovirus Vaccine Revenue by Application (2017-2028)
6.3 Global Poliovirus Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Poliovirus Vaccine Sales by Type (2017-2028)
7.2 North America Poliovirus Vaccine Sales by Application (2017-2028)
7.3 North America Poliovirus Vaccine Market Size by Country
7.3.1 North America Poliovirus Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Poliovirus Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Poliovirus Vaccine Sales by Type (2017-2028)
8.2 Europe Poliovirus Vaccine Sales by Application (2017-2028)
8.3 Europe Poliovirus Vaccine Market Size by Country
8.3.1 Europe Poliovirus Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Poliovirus Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Poliovirus Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Poliovirus Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Poliovirus Vaccine Market Size by Region
9.3.1 Asia-Pacific Poliovirus Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Poliovirus Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Poliovirus Vaccine Sales by Type (2017-2028)
10.2 South America Poliovirus Vaccine Sales by Application (2017-2028)
10.3 South America Poliovirus Vaccine Market Size by Country
10.3.1 South America Poliovirus Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Poliovirus Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Poliovirus Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Poliovirus Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Poliovirus Vaccine Market Size by Country
11.3.1 Middle East & Africa Poliovirus Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Poliovirus Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Poliovirus Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Poliovirus Vaccine
12.3 Poliovirus Vaccine Production Process
12.4 Poliovirus Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Poliovirus Vaccine Typical Distributors
13.3 Poliovirus Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Poliovirus Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Poliovirus Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Sanofi Basic Information, Manufacturing Base and Competitors
Table 4. Sanofi Major Business
Table 5. Sanofi Poliovirus Vaccine Product and Services
Table 6. Sanofi Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. GSK Basic Information, Manufacturing Base and Competitors
Table 8. GSK Major Business
Table 9. GSK Poliovirus Vaccine Product and Services
Table 10. GSK Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Bibcol Basic Information, Manufacturing Base and Competitors
Table 12. Bibcol Major Business
Table 13. Bibcol Poliovirus Vaccine Product and Services
Table 14. Bibcol Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Serum Institute Basic Information, Manufacturing Base and Competitors
Table 16. Serum Institute Major Business
Table 17. Serum Institute Poliovirus Vaccine Product and Services
Table 18. Serum Institute Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Tiantan Biological Basic Information, Manufacturing Base and Competitors
Table 20. Tiantan Biological Major Business
Table 21. Tiantan Biological Poliovirus Vaccine Product and Services
Table 22. Tiantan Biological Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. IMBCA Basic Information, Manufacturing Base and Competitors
Table 24. IMBCA Major Business
Table 25. IMBCA Poliovirus Vaccine Product and Services
Table 26. IMBCA Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Panacea Biotec Ltd Basic Information, Manufacturing Base and Competitors
Table 28. Panacea Biotec Ltd Major Business
Table 29. Panacea Biotec Ltd Poliovirus Vaccine Product and Services
Table 30. Panacea Biotec Ltd Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Bio-Med Basic Information, Manufacturing Base and Competitors
Table 32. Bio-Med Major Business
Table 33. Bio-Med Poliovirus Vaccine Product and Services
Table 34. Bio-Med Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Halfkin Bio-Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Halfkin Bio-Pharmaceuticals Major Business
Table 37. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product and Services
Table 38. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Global Poliovirus Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 40. Global Poliovirus Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 41. Market Position of Manufacturers in Poliovirus Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 42. Global Poliovirus Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 43. Head Office and Poliovirus Vaccine Production Site of Key Manufacturer
Table 44. Poliovirus Vaccine New Entrant and Capacity Expansion Plans
Table 45. Poliovirus Vaccine Mergers & Acquisitions in the Past Five Years
Table 46. Global Poliovirus Vaccine Sales by Region (2017-2022) & (K Units)
Table 47. Global Poliovirus Vaccine Sales by Region (2023-2028) & (K Units)
Table 48. Global Poliovirus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 49. Global Poliovirus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 50. Global Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 51. Global Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 52. Global Poliovirus Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 53. Global Poliovirus Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 54. Global Poliovirus Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 55. Global Poliovirus Vaccine Price by Type (2023-2028) & (USD/Unit)
Table 56. Global Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 57. Global Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 58. Global Poliovirus Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 59. Global Poliovirus Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 60. Global Poliovirus Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 61. Global Poliovirus Vaccine Price by Application (2023-2028) & (USD/Unit)
Table 62. North America Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 63. North America Poliovirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 64. North America Poliovirus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 65. North America Poliovirus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 66. North America Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 67. North America Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 68. North America Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 69. North America Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 70. Europe Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 71. Europe Poliovirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 72. Europe Poliovirus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 73. Europe Poliovirus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 74. Europe Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 75. Europe Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 76. Europe Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 77. Europe Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 78. Asia-Pacific Poliovirus Vaccine Sales by Region (2017-2022) & (K Units)
Table 79. Asia-Pacific Poliovirus Vaccine Sales by Region (2023-2028) & (K Units)
Table 80. Asia-Pacific Poliovirus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 81. Asia-Pacific Poliovirus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 82. Asia-Pacific Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 83. Asia-Pacific Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 84. Asia-Pacific Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 85. Asia-Pacific Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 86. South America Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)
Table 87. South America Poliovirus Vaccine Sales by Country (2023-2028) & (K Units)
Table 88. South America Poliovirus Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 89. South America Poliovirus Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 90. South America Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 91. South America Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 92. South America Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 93. South America Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 94. Middle East & Africa Poliovirus Vaccine Sales by Region (2017-2022) & (K Units)
Table 95. Middle East & Africa Poliovirus Vaccine Sales by Region (2023-2028) & (K Units)
Table 96. Middle East & Africa Poliovirus Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 97. Middle East & Africa Poliovirus Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 98. Middle East & Africa Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)
Table 99. Middle East & Africa Poliovirus Vaccine Sales by Type (2023-2028) & (K Units)
Table 100. Middle East & Africa Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)
Table 101. Middle East & Africa Poliovirus Vaccine Sales by Application (2023-2028) & (K Units)
Table 102. Poliovirus Vaccine Raw Material
Table 103. Key Manufacturers of Poliovirus Vaccine Raw Materials
Table 104. Direct Channel Pros & Cons
Table 105. Indirect Channel Pros & Cons
Table 106. Poliovirus Vaccine Typical Distributors
Table 107. Poliovirus Vaccine Typical Customers
List of Figures
Figure 1. Poliovirus Vaccine Picture
Figure 2. Global Poliovirus Vaccine Revenue Market Share by Type in 2021
Figure 3. Inactivated Polio Vaccine (IPV)
Figure 4. Oral Polio Vaccine (OPV)
Figure 5. Global Poliovirus Vaccine Revenue Market Share by Application in 2021
Figure 6. Public
Figure 7. Private
Figure 8. Global Poliovirus Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Poliovirus Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Poliovirus Vaccine Sales (2017-2028) & (K Units)
Figure 11. Global Poliovirus Vaccine Price (2017-2028) & (USD/Unit)
Figure 12. Global Poliovirus Vaccine Production Capacity (2017-2028) & (K Units)
Figure 13. Global Poliovirus Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Poliovirus Vaccine Market Drivers
Figure 15. Poliovirus Vaccine Market Restraints
Figure 16. Poliovirus Vaccine Market Trends
Figure 17. Global Poliovirus Vaccine Sales Market Share by Manufacturer in 2021
Figure 18. Global Poliovirus Vaccine Revenue Market Share by Manufacturer in 2021
Figure 19. Poliovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Poliovirus Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Poliovirus Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Poliovirus Vaccine Sales Market Share by Region (2017-2028)
Figure 23. Global Poliovirus Vaccine Revenue Market Share by Region (2017-2028)
Figure 24. North America Poliovirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 25. Europe Poliovirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Poliovirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. South America Poliovirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Poliovirus Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Global Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global Poliovirus Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global Poliovirus Vaccine Price by Type (2017-2028) & (USD/Unit)
Figure 32. Global Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 33. Global Poliovirus Vaccine Revenue Market Share by Application (2017-2028)
Figure 34. Global Poliovirus Vaccine Price by Application (2017-2028) & (USD/Unit)
Figure 35. North America Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 36. North America Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 37. North America Poliovirus Vaccine Sales Market Share by Country (2017-2028)
Figure 38. North America Poliovirus Vaccine Revenue Market Share by Country (2017-2028)
Figure 39. United States Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 43. Europe Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe Poliovirus Vaccine Sales Market Share by Country (2017-2028)
Figure 45. Europe Poliovirus Vaccine Revenue Market Share by Country (2017-2028)
Figure 46. Germany Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Poliovirus Vaccine Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Poliovirus Vaccine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Poliovirus Vaccine Revenue Market Share by Region (2017-2028)
Figure 55. China Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 62. South America Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 63. South America Poliovirus Vaccine Sales Market Share by Country (2017-2028)
Figure 64. South America Poliovirus Vaccine Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Poliovirus Vaccine Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Poliovirus Vaccine Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Poliovirus Vaccine Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Poliovirus Vaccine Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Poliovirus Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Poliovirus Vaccine in 2021
Figure 76. Manufacturing Process Analysis of Poliovirus Vaccine
Figure 77. Poliovirus Vaccine Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 経口ポリオワクチン（OPV）のグローバル市場展望 2023年-2029年：三価OPV、二価OPV
  • 不活化ポリオワクチンの世界市場2022：ヒト二倍体細胞、サル腎細胞
  • 帯状疱疹ワクチンの世界市場2022：生ワクチン、組換えワクチン
  • 混合ワクチンの世界市場2022：3組、4組、5組、その他
  • 水痘ウイルスワクチンの世界市場2022：子供用、大人用
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22DC3896 )"ポリオワクチンの世界市場2022：不活化ポリオワクチン（IPV）、経口ポリオワクチン（OPV）" (英文：Global Poliovirus Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。